Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (149)	9/29/2006 2:09:22 AM
From: Ian@SI	Read Replies (1) \| Respond to of 507

I suspect that the amount of competition will depend, in part, on how successful PFE/NKTR is. I suppose this extended introductory period should allow all involved to become somewhat more reassured re safety. Even though, you guys keep telling me that better compliance will outweigh safety issues, I keep coming back to that. Time will tell. good luck, Ian

To: tuck who wrote (149)	10/8/2006 10:56:08 PM
From: Rocky9	Respond to of 507

"I failed to sell calls against my shares before the "launch" and so suffered the price decline, but I kept selling more puts. So this bounce makes up for most of that. I closed that sold put position today because I suspect a pullback is in the offing, but having lathered and rinsed, I intend to repeat." I likewise did not sell calls. But I also did not sell any puts. Have been thinking about it for a while and may still do it. A relatively small position, but one where I was very hopeful. May still be okay.